Founded Year
1991Stage
Acq - P2P | AcquiredTotal Raised
$39.29MValuation
$0000Latest CuraGen News
Jul 13, 2021
BOULDER — Clovis Oncology (NYSE: CLVS) is increasing the number of directors on its board from 10 to 11 and filling that vacancy with Dr. Ronit Simantov, the company announced Monday in a news release. Simantov is the chief medical officer at the cell-therapy company Gamida Cell Ltd. She had previously served as vice president for oncology global medical affairs at Pfizer Inc, with other experience at OSI Pharmaceuticals, CuraGen Corporation and Bayer HealthCare Pharmaceuticals. Simantov will receive $55,000 in annual cash retainers for her role on the board. She will also receive a one-time option to purchase 83,212 shares of Clovis Oncology stock. © 2021 BizWest Media LLC BOULDER — Clovis Oncology (NYSE: CLVS) is increasing the number of directors on its board from 10 to 11 and filling that vacancy with Dr. Ronit Simantov, the company announced Monday in a news release. Simantov is the chief medical officer at the cell-therapy company Gamida Cell Ltd. She had previously served as vice president for oncology global medical affairs at Pfizer Inc, with other experience at OSI Pharmaceuticals, CuraGen Corporation and Bayer HealthCare Pharmaceuticals. Simantov will receive $55,000 in annual cash retainers for her role on the board. She will also receive a one-time option to purchase 83,212 shares of Clovis Oncology stock. © 2021 BizWest Media LLC
Expert Collections containing CuraGen
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
CuraGen is included in 1 Expert Collection, including Biopharmaceuticals.
Biopharmaceuticals
14,140 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
CuraGen Patents
CuraGen has filed 4 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
11/26/2014 | 5/14/2019 | Glucocorticoids, Oncology, Antineoplastic drugs, Experimental cancer drugs, Cancer treatments | Grant | |
Application Date | 11/26/2014 | |||
|---|---|---|---|---|
Grant Date | 5/14/2019 | |||
Title | ||||
Related Topics | Glucocorticoids, Oncology, Antineoplastic drugs, Experimental cancer drugs, Cancer treatments | |||
Status | Grant |